tiprankstipranks
Arcutis Biotherapeutics (ARQT)
NASDAQ:ARQT
US Market

Arcutis Biotherapeutics (ARQT) Financial Statements

670 Followers

Arcutis Biotherapeutics Financial Overview

Arcutis Biotherapeutics's market cap is currently ―. The company's EPS TTM is $-2.915; its P/E ratio is -3.34; Arcutis Biotherapeutics is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-0.52. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 49.57M$ 13.53M$ 38.11M$ 5.19M$ 2.78M
Gross Profit$ 46.31M$ 10.50M$ 38.11M$ 4.77M$ 2.78M
EBIT$ -27.58M$ -58.50M$ -31.82M$ -62.09M$ -71.49M
EBITDA$ -27.22M$ -58.11M$ -32.87M$ -63.44M$ -73.20M
Net Income Common Stockholders$ -35.38M$ -66.28M$ -42.40M$ -70.99M$ -80.10M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 403.87M$ 271.86M$ 227.11M$ 268.67M$ 333.31M
Total Assets$ 478.52M$ 341.37M$ 292.96M$ 320.66M$ 377.36M
Total Debt$ 206.74M$ 205.92M$ 205.07M$ 204.22M$ 203.38M
Net Debt$ -197.13M$ -65.94M$ -22.05M$ -64.45M$ -129.93M
Total Liabilities$ 253.60M$ 252.70M$ 246.24M$ 240.18M$ 239.73M
Stockholders Equity$ 224.93M$ 88.67M$ 46.72M$ 80.46M$ 139.70M
Cash Flow-
Free Cash Flow$ -31.60M$ -56.25M$ -44.05M$ -66.76M$ -80.43M
Operating Cash Flow$ -31.60M$ -56.24M$ -43.98M$ -66.48M$ -80.34M
Investing Cash Flow$ -28.70M$ -62.19M$ 45.55M$ 89.12M$ 107.75M
Financing Cash Flow$ 161.76M$ 99.29M$ 867.00K$ 1.07M$ 100.00K
Currency in USD

Arcutis Biotherapeutics Earnings and Revenue History

Arcutis Biotherapeutics Debt to Assets

Arcutis Biotherapeutics Cash Flow

Arcutis Biotherapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis